2023
DOI: 10.1007/s11764-022-01323-8
|View full text |Cite
|
Sign up to set email alerts
|

Quality of care and quality of life as experienced by patients with advanced cancer of a rare tumour type: results of the multicentre observational eQuiPe study

Abstract: Purpose Patients with a rare cancer face di culties during their disease trajectory, such as delayed diagnosis and lack of expert care. However, little is known about their perceived Quality of Care (QoC) and Quality of Life (QoL) in the advanced disease stage. We aimed to assess the QoC and QoL as experienced by patients with advanced rare cancers compared to patients with advanced common cancers.Methods In this cross-sectional study, baseline data of patients with advanced cancer from the multicentre, longit… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 55 publications
0
1
0
Order By: Relevance
“…Nor did they address cancer in young adults, who are a population with specific needs that are reportedly unmet by the health service (LaRosa et al, 2017). Patients with advanced rare cancer often complain of lower continuity of care and social functioning compared with those with advanced common cancers, and no studies address the impact of the case manager as a liaison between different health care professionals to improve continuity of care in rare cancers (van Oss et al, 2023).…”
mentioning
confidence: 99%
“…Nor did they address cancer in young adults, who are a population with specific needs that are reportedly unmet by the health service (LaRosa et al, 2017). Patients with advanced rare cancer often complain of lower continuity of care and social functioning compared with those with advanced common cancers, and no studies address the impact of the case manager as a liaison between different health care professionals to improve continuity of care in rare cancers (van Oss et al, 2023).…”
mentioning
confidence: 99%